Terray Therapeutics Overview
- Founded
- 2018
- Status
- Private
- Employees
- 50
- Latest Deal Type
- Series A
- Latest Deal Amount
- $60M
- Investors
- 9
Terray Therapeutics General Information
Description
Operator of a biotechnology company designed to provide precise chemical datasets that are built to propel drug discovery. The company uses artificial intelligence, synthetic chemistry, automation, and nanotechnology to generate the chemical datasets using ultra-dense microarray technology work seamlessly with the integrated machine learning and computational platform to systematically map biochemical interactions between small molecules and causes of disease and iterative cycles of virtual molecular design and experimentation power AI and machine learning models that in turn guide the next cycle of design, enabling doctors to derive insights to predict and create drugs for patients in need.
Contact Information
Website
www.terraytx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Discovery
Biotechnology
Primary Office
- 129 N Hill Avenue
- Suite 103
- Pasdena, CA 91106-1961
- United States
+1 (347) 000-0000
Terray Therapeutics Timeline
Terray Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC (Series A) | 15-Feb-2022 | $60M | 000.00 | 00000 | Completed | Generating Revenue |
| 3. Seed Round | 30-Jun-2021 | 0000 | 000.00 | Completed | Generating Revenue | |
| 2. Seed Round | 13-Mar-2019 | $5M | $6.3M | 0000 | Completed | Generating Revenue |
| 1. Seed Round | $1.3M | $1.3M | Completed | Startup |
Terray Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 0,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Seed-2 | 0,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.00 |
| Seed-1 | 1,771,776 | $0.000010 | 6% | $0.78 | $0.78 | 1x | $0.78 | 5.96% |
| Seed | 5,107,771 | $0.000010 | 6% | $0.98 | $0.98 | 1x | $0.98 | 17.17% |
Terray Therapeutics Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Jacob Berlin Ph.D | Co-Founder, Chief Executive Officer & Board Member | ||
| Eli Berlin | Co-Founder, Chief Operating Officer, Chief Financial Officer & Board Member |
Terray Therapeutics Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| Christopher Picardo | Madrona Venture Group | Board Member | 000 0000 |
| Dusan Perovic | Two Sigma Ventures | Board Member | 000 0000 |
| Eli Berlin | Terray Therapeutics | Co-Founder, Chief Operating Officer, Chief Financial Officer & Board Member | 000 0000 |
| Geoffrey Smith JD | Digitalis Ventures | Board Member | 000 0000 |
| Jacob Berlin Ph.D | Terray Therapeutics | Co-Founder, Chief Executive Officer & Board Member | 000 0000 |
Terray Therapeutics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialTerray Therapeutics Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Alexandria Venture Investments | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
| Goldcrest Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Greentrail Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| XTX Ventures | Corporation | Minority | 000 0000 | 000000 0 | |
| Madrona Venture Group | Venture Capital | Minority | 000 0000 | 000000 0 |